Aurinia Pharmaceuticals Inc (AUPH.OQ)
22 Feb 2018
Thu, Jan 4 2018
* AURINIA PHARMACEUTICALS INC FILES FOR MIXED SHELF OF UP TO $250 MILLION – SEC FILING Source text: [http://bit.ly/2CTvkK1] Further company coverage:
* AURINIA PHARMACEUTICALS ADDED TO THE NASDAQ BIOTECH INDEX Source text for Eikon: Further company coverage:
* Aurinia reports third quarter 2017 financial results and provides operational highlights
* Robert Duggan reports 5.9 percent stake in Aurinia Pharmaceuticals Inc as on October 19, 2017 - SEC filing
* Aurinia Pharmaceuticals Inc - plans to expand voclosoprin renal franchise to include focal segmental glomerulosclerosis and minimal change disease
- Aurinia Pharmaceuticals: Will AURORA Light The Way To Voclosporin's Approval?
- Aurinia Pharmaceuticals: Potential Rewards Far Outweigh The Risks
- Aurinia Pharmaceuticals' Voclosporin: A Blockbuster Drug Hidden In Plain Sight?
- Bristol-Myers Squibb's Abatacept Compared Against Aurinia Pharmaceuticals' Voclosporin In The Treatment Of Lupus Nephritis Patients
- Addressing Concerns With Aurinia Pharmaceuticals COO Michael Martin
- 3 Reasons To Buy Aurinia Pharmaceuticals